Florence Pasquier

1.5k total citations
23 papers, 339 citations indexed

About

Florence Pasquier is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Florence Pasquier has authored 23 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Florence Pasquier's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Florence Pasquier is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Florence Pasquier collaborates with scholars based in France, Belgium and Japan. Florence Pasquier's co-authors include William Vainchenker, Stéphane Giraudier, Stefan N. Constantinescu, Carole Tonetti, Rodolphe Besancenot, Yann Lécluse, Caroline Marty, Ronan Chaligné, Isabelle Plo and Stéphane de Botton and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS Biology.

In The Last Decade

Florence Pasquier

21 papers receiving 331 citations

Peers

Countries citing papers authored by Florence Pasquier

Since Specialization

Citations

This map shows the geographic impact of Florence Pasquier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Pasquier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Pasquier more than expected).

Fields of papers citing papers by Florence Pasquier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Pasquier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Pasquier. The network helps show where Florence Pasquier may publish in the future.

Co-authorship network of co-authors of Florence Pasquier

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Pasquier. A scholar is included among the top collaborators of Florence Pasquier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Pasquier. Florence Pasquier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deregulation of the p19/CDK4/CDK6 axis in Jak2V617F megakaryocytes accelerates the development of myelofibrosis 2024 ·Leukemia ·(unknown), Delphine Muller, Laure Gilles, (unknown), Mira El-Khoury, (unknown), Najet Debili, M. Wittner, Alexandre Kauskot, Florence Pasquier, Iléana Antony‐Debré, Caroline Marty, William Vainchenker, Isabelle Plo, Hana Raslová	1
2	New approaches to standard of care in early-phase myeloproliferative neoplasms: can interferon-α alter the natural history of the disease? 2024 ·Haematologica ·Florence Pasquier, (unknown), (unknown), (unknown), Isabelle Plo	0
3	CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia 2023 ·Journal of Clinical Medicine ·Khalil Saleh, Florence Pasquier, Camille Bigenwald, Stéphane de Botton, Vincent Ribrag, Cristina Castilla‐Llorente	7
4	An inherited gain‐of‐function risk allele in EPOR predisposes to familial JAK2^V617F myeloproliferative neoplasms 2022 ·British Journal of Haematology ·(unknown), Florence Pasquier, Christophe Marzac, Éric Deconinck, (unknown), (unknown), Mira El-Khoury, Wassim El Nemer, Jean‐Jacques Kiladjian, Hana Raslová, A Najman, William Vainchenker, Caroline Marty, Christine Bellanné‐Chantelot, Isabelle Plo	7
5	High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL 2022 ·Haematologica ·Aurélie Cabannes‐Hamy, Éolia Brissot, Thibaut Leguay, Françoise Huguet, Patrice Chevallier, Mathilde Hunault, Martine Escoffre‐Barbe, Thomas Cluzeau, Marie Balsat, Stéphanie Nguyen, Florence Pasquier, Magda Alexis, Véronique Lhéritier, Cédric Pastoret, Éric Delabesse, Emmanuelle Clappier, Hervé Dombret, Nicolas Boissel	24
6	JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML 2020 ·The Journal of Experimental Medicine ·(unknown), Nabih Maslah, Valérie Edmond, Bruno Cassinat, William Vainchenker, Stéphane Giraudier, Florence Pasquier, Emmanuelle Verger, Michiko Niwa‐Kawakita, Valérie Lallemand-Breitenbach, Isabelle Plo, Jean‐Jacques Kiladjian, Jean‐Luc Villeval, Hugues de Thé	19
7	Ivosidenib to treat adult patients with relapsed or refractoryacute myeloid leukemia 2020 ·Drugs of today ·Florence Pasquier, Marc Lecuit, Sophie Broutin, Sofiane Saada, A. Jeanson, Virginie Penard‐Lacronique, Stéphane de Botton	5
8	Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation 2020 ·Expert Review of Precision Medicine and Drug Development ·Florence Pasquier, Claude Chahine, Christophe Marzac, Stéphane de Botton	3
9	Myelodysplastic Syndrome in Hemodialysis Patients 2019 ·Kidney International Reports ·(unknown), Florence Pasquier, Khalil El Karoui, Marion Sallée, Stanislas Faguer, T. Krummel, Laurence Nicolet, Thibault Dolley‐Hitze, Vincent Audard, Christophe Ridel, Jean‐Baptiste Micol, Maxime Touzot	3
10	Efficacy of 5-Azacitidine on IDH1/2 Acute Myeloid Leukemia/Myelodysplastic Syndromes and Correlation with 2-Hydroxyglutarate Production 2017 ·Blood ·Christophe Willekens, Véronique Saada, Sophie Broutin, (unknown), Aline Renneville, (unknown), Christophe Marzac, Jean‐Baptiste Micol, Éric Solary, Florence Pasquier, Julien Lazarovici, Vincent Ribrag, Claude Preudhomme, Cyril Quivoron, Virginie Penard‐Lacronique, Angélo Paci, Stéphane de Botton	1
11	New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis 2017 ·Haematologica ·Florence Pasquier, Caroline Marty, Thomas Balligand, Frédèrique Verdier, (unknown), Vitalina Gryshkova, Hana Raslová, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, Christine Bellanné-Chantelot, Isabelle Plo	13
12	Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies 2015 ·Journal of Medical Microbiology ·Paul‐Louis Woerther, Jean‐Baptiste Micol, Cécile Angebault, Florence Pasquier, Sylvain Pilorge, Jean Bourhis, Stéphane de Botton, Bertrand Gachot, Élisabeth Chachaty	12
13	Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy 2014 ·Clinical Lymphoma Myeloma & Leukemia ·Florence Pasquier, Xénia Cabagnols, (unknown), Isabelle Plo, William Vainchenker	23
14	JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation 2014 ·Blood ·Rodolphe Besancenot, Damien Roos‐Weil, Carole Tonetti, (unknown), Catherine Lacout, Florence Pasquier, Christophe Willekens, Philippe Rameau, Yann Lécluse, Jean‐Baptiste Micol, Stefan N. Constantinescu, William Vainchenker, Éric Solary, Stéphane Giraudier	43
15	Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis 2013 ·European Journal of Cancer ·David Ghez, Jean‐Baptiste Micol, Florence Pasquier, Nathalie Auger, Véronique Saada, Marc Spentchian, Jean‐Christophe Ianotto, Jean Bourhis, (unknown), Christine Terré, Sylvie Castaigné, Sophie Rigaudeau, Philippe Rousselot, Stéphane de Botton	16
16	CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model 2012 ·Cell Death and Disease ·(unknown), Satyananda Patel, (unknown), M. Wittner, Christophe Willekens, Song Shen, (unknown), V. Joulin, Paule Opolon, Olivia Bawa, Florence Pasquier, Mamoru Ito, Nobutaka Fujii, Patrick Gonin, Éric Solary, William Vainchenker, Paul Coppo, Stéphane de Botton, Fawzia Louache	52
17	A Senescence-Like Cell-Cycle Arrest Occurs During Megakaryocytic Maturation: Implications for Physiological and Pathological Megakaryocytic Proliferation 2010 ·PLoS Biology ·Rodolphe Besancenot, Ronan Chaligné, Carole Tonetti, Florence Pasquier, Caroline Marty, Yann Lécluse, William Vainchenker, Stefan N. Constantinescu, Stéphane Giraudier	80
18	[Mental akinesia and memory disorders following carbon monoxide poisoning]. 1991 ·PubMed ·(unknown), Florence Pasquier, H Petit	3
19	Acute polyradiculoneuropathy after amitriptyline overdose. 1987 ·BMJ ·Didier Leys, Florence Pasquier, Marie‐Dominique Lamblin, F Dubois, (unknown)	10
20	[Benign choroid plexus papilloma. 2 local recurrences and intraventricular seeding]. 1986 ·PubMed ·Didier Leys, Florence Pasquier, (unknown), F Lesoin, (unknown), (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact